ethris SNIM® RNA-Technology represents a novel nucleic acid therapy platform based on stabilized non-immunogenic messenger RNA (mRNA). In contrast to commonly used mRNA, SNIM® RNA can be administered repeatedly leading to sustained expression of therapeutically active proteins even at low doses. This can be used in the therapy of hereditary diseases, as an alternative to protein therapy, and in regenerative medicine. ethris calls it “Transcript Therapy”.